In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

EHJ – Cardiovascular Pharmacotherapy

Specific Focus on Clinical Cardiovascular Pharmacology


The European Heart Journal – Cardiovascular Pharmacotherapy (EHJ-CVP) is the official journal of the European Society of Cardiology and the ESC Working Group on Cardiovascular Pharmacotherapy. The journal reports on the interpretation and integration of new scientific developments  to improve the pharmacological treatment of patients with cardiovascular disease.

It publishes original articles on clinical research, with new and established drugs and methods, as well as meta-analysis and topical reviews.


Fast Facts

  • Editor-in-chief: Stefan Agewall FESC, NO
  • Current volume: 6 (year 2020)
  • Issues per subscription: 4
  • Impact Factor 2019: 6.696


Editor in chief History

Name Start Date End Date
 Professor Stefan Agewall 01/01/2015  
Updates on latest articles

Updates on latest articles


Receive the table of contents in your mailbox.

Track topics and authors important to you and receive articles in your mailbox.

For Authors

Before being published, all manuscripts go through double-blind, peer review by experienced international experts.

Most recent articles from EHJ-CVP

15 Sep 2020
Minimizing bleeding events
Author(s):Agewall S.
20 Jul 2020
Cardiovascular pharmacotherapy in older people: challenges posed by cardiovascular drug prescription in the elderly
Author(s):Kaski J, Tamargo J, Savarese G.
16 Aug 2020
Corrigendum to: Oral anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1: a current opinion of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Council on Stroke and Low quality of some generic cardiovascular medicinal products represents a matter for growing concern
17 Jul 2020
COVID-19: how things change in a short while
Author(s):Stolfo D, Sinagra G.